Skip to Content

Rabies Immune Globulin

Last Updated: April 9, 2018
Status: Resolved

Mepivacaine Injection

Products Affected - Description
    • Carbocaine injection, Pfizer, 1%, 30 mL preservative-free vial, NDC 00409-1036-30
    • Carbocaine injection, Pfizer, 1%, 50 mL multiple dose vial, NDC 00409-1038-50
    • Carbocaine injection, Pfizer, 1.5%, 30 mL preservative-free vial, NDC 00409-1041-30
    • Carbocaine injection, Pfizer, 2%, 20 mL preservative-free vial, NDC 00409-1067-20
Reason for the Shortage
    • Fresenius Kabi has Polocaine and Polocaine-MPF available.
    • Pfizer states the reason for the shortage is manufacturing delays.
Available Products
    • Carbocaine injection, Pfizer, 2%, 50 mL multiple dose vial, NDC 00409-2047-50
    • Polocaine injection, Fresenius Kabi, 1%, 50 mL multiple dose vial, NDC 63323-0283-57
    • Polocaine injection, Fresenius Kabi, 2%, 50 mL multiple dose vial, NDC 63323-0296-57
    • Polocaine-MPF injection, Fresenius Kabi, 1%, 30 mL preservative-free vial, NDC 63323-0260-37
    • Polocaine-MPF injection, Fresenius Kabi, 1.5%, 30 mL preservative-free vial, NDC 63323-0293-37
    • Polocaine-MPF injection, Fresenius Kabi, 2%, 20 mL preservative-free vial, NDC 63323-0294-27

Estimated Resupply Dates

    • Pfizer has Carbocaine 2% 20 mL preservative-free vials, 1% 30 mL preservative-free vials, 1% 50 mL multiple-dose vials, and 1.5% 30 mL preservative-free vials on back order and the company estimates a release date of March 2019.

Updated

Updated April 9, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 9, 2017 by Elyse MacDonald, PharmD, MS, BCPS. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide